Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioNano Genomics Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS
Ticker
Exchange
SIC #
Website
Latest Ticker
BNGO
Nasdaq
3826
https://bionano.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioNano Genomics Inc
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
- Apr 17th, 2024 12:00 pm
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
- Apr 11th, 2024 12:00 pm
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- Apr 4th, 2024 5:44 pm
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
- Apr 3rd, 2024 12:00 pm
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting
- Apr 2nd, 2024 12:00 pm
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance
- Mar 19th, 2024 12:00 pm
Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript
- Mar 7th, 2024 4:47 pm
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System
- Mar 7th, 2024 1:00 pm
Q4 2023 Bionano Genomics Inc Earnings Call
- Mar 6th, 2024 11:44 am
Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript
- Mar 6th, 2024 5:30 am
Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024
- Mar 5th, 2024 9:01 pm
Bionano to Present at TD Cowen’s 44th Annual Health Care Conference
- Feb 29th, 2024 1:00 pm
Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024
- Feb 28th, 2024 1:01 pm
Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway
- Feb 28th, 2024 1:00 pm
American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
- Feb 22nd, 2024 1:00 pm
7 Penny Stocks to Buy on the Dip: February 2024
- Feb 7th, 2024 6:10 pm
Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Jan 31st, 2024 1:00 pm
Bionano’s Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS
- Jan 30th, 2024 1:00 pm
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer
- Jan 25th, 2024 1:00 pm
Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing
- Jan 24th, 2024 1:00 pm
Scroll